Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer/Pharmacia update

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia CEO Fred Hassan will earn annual base salary of $1.5 mil. with an annual incentives target of 125% of base salary as Pfizer vice chairman, according to Pfizer's Aug. 14 1S-4 filing with SEC. Hassan also will be entitled to receive an equity award in the first year of 900,000 Pfizer stock options. Upon retirement, he will serve as a Pfizer consultant earning $850,000 per year. In other personnel news, Pharmacia senior execs offered positions at Pfizer include Pharmacia's President-R&D Goran Ando, MD, and Chief Scientific Officer Phillip Needleman, PhD. Notable absentees from the list include Pharmacia's Senior VP-Global Regulatory Affairs John Landis and President-North American Operations Mark Spiers...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel